• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入术对急性心肌梗死合并 2 型糖尿病患者血栓形成倾向的影响。

IMPACT OF PERCUTANEOUS CORONARY INTERVENTION ON PROTHROMBOGENIC POTENTIAL IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND DIABETES MELLITUS TYPE 2.

机构信息

KHARKIV NATIONAL MEDICAL UNIVERSITY, KHARKIV, UKRAINE.

出版信息

Wiad Lek. 2022;75(2):339-343.

PMID:35307655
Abstract

OBJECTIVE

The aim: Aim of study is to assess the influence of urgent reperfusion strategy on the levels of vWf, PAI-1 and sCD40L in patients with acute myocardial infarction (AMI) and concomitant diabetes mellitus type 2 (DM2).

PATIENTS AND METHODS

Materials and methods: 255 patients with acute myocardial infarction took part in the study, they were divided into four groups depending on the presence of concomitant diabetes mellitus type 2 and performed treatment: I group - 83 diabetic patients who were underwent urgent reperfusion therapy; II group - 60 diabetic patients who received standard anticoagulant therapy; III group - 65 non-diabetic patients who were underwent urgent reperfusion therapy; IV group - 47 non-diabetic patients who received standard anticoagulant therapy. The levels of von Willebrand factor, PAI-1 and sCD40L were determined by enzyme-linked immunosorbent assay. Statistical data were processed using the Mann-Whitney U-test, the Kruskal-Wallis H-test, quantitative variables were described by the following parameters: median (Me), 25th and 75th percentiles (Q1; Q3).

RESULTS

Results: According to obtained data, we can conclude that patients with acute myocardial infarction and concomitant type 2 diabetes mellitus have higher levels of von Willebrand factor, PAI-1 and sCD40L compared to non-diabetic patients with AMI, which leads to the increasing of the platelets adhesion and aggregation and decreasing of fibrinolysis.

CONCLUSION

Conclusions: Urgent restoration of blood supply in occluded artery contributed to a statistically significant reduction in levels of von Willebrand factor, PAI-1 and sCD40L levels in both diabetics and non-diabetic patients, reducing the risk of thromboembolic complications and thus improving the prognosis.

摘要

目的

研究目的是评估急性心肌梗死(AMI)合并 2 型糖尿病(DM2)患者中紧急再灌注策略对 vWf、PAI-1 和 sCD40L 水平的影响。

患者和方法

共有 255 例 AMI 患者参与本研究,根据是否合并 2 型糖尿病分为四组,分别接受以下治疗:I 组-83 例接受紧急再灌注治疗的糖尿病患者;II 组-60 例接受标准抗凝治疗的糖尿病患者;III 组-65 例接受紧急再灌注治疗的非糖尿病患者;IV 组-47 例接受标准抗凝治疗的非糖尿病患者。采用酶联免疫吸附试验测定 vWf、PAI-1 和 sCD40L 水平。采用 Mann-Whitney U 检验、Kruskal-Wallis H 检验对统计数据进行处理,定量变量采用中位数(Me)、25 分位数(Q1)和 75 分位数(Q3)表示。

结果

根据所得数据,我们可以得出结论,与非糖尿病 AMI 患者相比,急性心肌梗死合并 2 型糖尿病患者的 vWf、PAI-1 和 sCD40L 水平更高,导致血小板黏附和聚集增加,纤溶降低。

结论

闭塞动脉的紧急血运重建有助于显著降低糖尿病和非糖尿病患者的 vWf、PAI-1 和 sCD40L 水平,降低血栓栓塞并发症的风险,从而改善预后。

相似文献

1
IMPACT OF PERCUTANEOUS CORONARY INTERVENTION ON PROTHROMBOGENIC POTENTIAL IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND DIABETES MELLITUS TYPE 2.经皮冠状动脉介入术对急性心肌梗死合并 2 型糖尿病患者血栓形成倾向的影响。
Wiad Lek. 2022;75(2):339-343.
2
Time course of endothelial dysfunction and atherothrombosis markers in patients with acute myocardial infarction with st segment elevation and type 2 diabetes mellitus depending on reperfusion therapy approach.根据再灌注治疗方法,ST段抬高型急性心肌梗死合并2型糖尿病患者内皮功能障碍和动脉粥样硬化血栓形成标志物的时间进程。
Wiad Lek. 2020;73(1):123-127.
3
IMPACT OF PERCUTANEOUS CORONARY INTERVENTION ON MARKERS OF MATRIX DEGRADATION AND ENDOTHELIAL-DEPENDENT MEDIATORS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND DIABETES MELLITUS TYPE 2.经皮冠状动脉介入治疗对急性心肌梗死合并2型糖尿病患者基质降解标志物和内皮依赖性介质的影响
Georgian Med News. 2020 Feb(299):70-74.
4
Sex-specific outcomes of diabetic patients with acute myocardial infarction who have undergone percutaneous coronary intervention: a register linkage study.经皮冠状动脉介入治疗的糖尿病急性心肌梗死患者的性别特异性结局:一项注册关联研究。
Cardiovasc Diabetol. 2012 Aug 11;11:96. doi: 10.1186/1475-2840-11-96.
5
[Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].[心肌梗死及其他冠心病危险因素患者的纤溶系统]
Sangre (Barc). 1994 Apr;39(2):111-6.
6
Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?急性心肌梗死溶栓治疗后糖尿病患者再灌注受损的酶学证据:纤溶酶原激活物抑制剂起作用了吗?
Br Heart J. 1993 Dec;70(6):530-6. doi: 10.1136/hrt.70.6.530.
7
[Impact of type 2 diabetes mellitus on the progression and revascularization of coronary non-target lesions in patients with coronary heart disease].[2型糖尿病对冠心病患者冠状动脉非靶病变进展及血管重建的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 May 24;48(5):393-400. doi: 10.3760/cma.j.cn112148-20190425-00204.
8
[Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention].通心络胶囊对急性心肌梗死患者延迟经皮冠状动脉介入治疗后心肌梗死溶栓中血小板活化因子、血管内皮功能及血流的影响
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016 Apr;36(4):415-20.
9
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.循证治疗的应用不足部分解释了糖尿病急性心肌梗死患者预后不良的原因。
Eur Heart J. 2003 May;24(9):838-44. doi: 10.1016/s0195-668x(02)00828-x.
10
Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention.接受直接经皮冠状动脉介入治疗的糖尿病患者的心力衰竭
Eur Heart J Acute Cardiovasc Care. 2016 Oct;5(6):455-462. doi: 10.1177/2048872615598632. Epub 2015 Jul 30.

引用本文的文献

1
Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients.血小板糖蛋白 Ib(GPIb)可能充当 2 型糖尿病(T2DM)与动脉粥样硬化之间的桥梁,使其成为 T2DM 患者抗血小板药物的潜在靶点。
Life (Basel). 2023 Jun 29;13(7):1473. doi: 10.3390/life13071473.